O'Shaughnessy Asset Management’s Coherus Oncology CHRS Stock Holding History

O'Shaughnessy Asset Management’s Portfolio CHRS Stock Details CHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-37,207	Closed	-$52.8K	–	2688
2025 Q4	$52.8K	Sell	37,207 -25,949	-41%	-$37.8K	﹤0.01%	2236
2025 Q3	$104K	Buy	+63,156	New	+$70.2K	﹤0.01%	2083
2021 Q4	–	Sell	-1,354	Closed	-$22K	–	1460
2021 Q3	$22K	Hold	1,354	–	–	﹤0.01%	1915
2021 Q2	$19K	Buy	1,354 +1,127	+496%	+$16K	﹤0.01%	1856
2021 Q1	$3K	Hold	227	–	–	﹤0.01%	2006
2020 Q4	$4K	Hold	227	–	–	﹤0.01%	1709
2020 Q3	$4K	Hold	227	–	–	﹤0.01%	1511
2020 Q2	$4K	Buy	+227	New	+$3.84K	﹤0.01%	1395
2020 Q1	–	Sell	-227	Closed	-$4K	–	1375
2019 Q4	$4K	Buy	+227	New	+$4.19K	﹤0.01%	1495

Other funds holding CHRS

TGY2IT

Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

O'Shaughnessy Asset Management's CHRS Position: Q1 2026 in Review

O'Shaughnessy Asset Management sold out of Coherus Oncology (CHRS) in Q1 2026, closing a stake of 37,207 shares — an estimated $52.8K sold.

O'Shaughnessy Asset Management first reported a position in CHRS in Q4 2019 and held it in 9 quarters. The position peaked at $104K in Q3 2025. 158 funds tracked by Wall St. Rank hold CHRS as of Q1 2026.

O'Shaughnessy Asset Management reported no remaining Coherus Oncology position as of Q1 2026 after selling out during the quarter.
O'Shaughnessy Asset Management sold 37,207 Coherus Oncology shares in Q1 2026, an estimated $52.8K.
O'Shaughnessy Asset Management first reported a position in Coherus Oncology in Q4 2019 and held it in 9 quarters.
O'Shaughnessy Asset Management's Coherus Oncology position peaked at $104K in Q3 2025.
158 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q1 2026, filed 13 May 2026.